The trucking industry is worth hundreds of billions of dollars per year. Uber is going after this market with Uber Freight, an online platform that matches truckers with...Technologyread more
Drone strikes attacked an oil processing facility at Abqaiq and the nearby Khurais oil field on Saturday.Marketsread more
Trump said oil would be released if needed to keep the market well supplied and he would expedite the approval of pipelines in Texas and other states.Marketsread more
Saudi Aramco is aiming to restore by Monday about a third of its crude output that was disrupted after drone attacks on two key oil facilities, The Wall Street Journal...Marketsread more
Apple's new iPhones can still send texts, download apps, and make video calls, but the company spends a lot of time and effort marketing its new phones as powerful photography...Technologyread more
Some U.S. manufacturers say tariffs, if targeted, will help address longstanding unfair trade practices like intellectual property theft.Traderead more
Supporters of a $15 minimum wage ballot initiative in Florida argue the state's inflation-tied pay hikes have not gone far enough.2020 Electionsread more
Saudi Arabia shut down half its oil production Saturday after drone strikes hit the world's largest oil processing facility in an attack claimed by Yemen's Houthi rebels.Politicsread more
Trusii's hydrogen water machines were supposed to help users with their health problems, but customers claim the company is involved in a giant scam.Technologyread more
The decoupling of the world's two weightiest economies seems as inescapable as its extent and global impact remains incalculable.Politicsread more
BlackBerry has reinvented itself to become a leader in securing mobile communications and in embedded communications. Next year it plans to roll out new products. CEO John...Evolveread more
Google on Friday announced a new health care and medicines policy that bans advertising for "unproven or experimental medical techniques," which it says includes most stem cell, cellular and gene therapies.
A blog post from Google policy advisor Adrienne Biddings said the company will prohibit ads selling treatments "that have no established biomedical or scientific basis." It will also extend the policy to treatments that are rooted in scientific findings and preliminary clinical experience "but currently have insufficient formal clinical testing to justify widespread clinical use." The change was first reported by The Washington Post.
The new Google ads policy may put the heat on for the stem cell clinic industry, which has until recently been largely unregulated and has some players who have been accused of taking advantage of seriously ill patients, The Washington Post reported.
"We know that important medical discoveries often start as unproven ideas — and we believe that monitored, regulated clinical trials are the most reliable way to test and prove important medical advances," Biddings said. "At the same time, we have seen a rise in bad actors attempting to take advantage of individuals by offering untested, deceptive treatments. Often times, these treatments can lead to dangerous health outcomes and we feel they have no place on our platforms."
The Google post included a quote from the president of the International Society for Stem Cell Research, Deepak Srivastava, who said the new policy is a "much-needed and welcome step to curb the marketing of unscrupulous medical products such as unproven stem cell therapies."
"While stem cells have great potential to help us understand and treat a wide range of diseases, most stem cell interventions remain experimental and should only be offered to patients through well-regulated clinical trials," he said. "The premature marketing and commercialization of unproven stem cell products threatens public health, their confidence in biomedical research, and undermines the development of legitimate new therapies."
The company said it will continue to allow advertising for research for clinical trials and for clinicians to promote research findings to the public. Google said as new findings are released and regulatory bodies oversee developments, the company will continue to update its policies as needed.
In a statement, the president of the American Medical Association, Patrice Harris, said the group is concerned that advertising treatments without established biomedical or scientific basis can promote misinformation "that provides false hope, undermines proper care and encourages ill-informed medical decisions."
"The American Medical Association believes it is critical to distinguish between treatments that have been validated by appropriate scientific study, those that are promising, and those that are without foundation," she said. "The AMA is pleased to see that Google appreciates the seriousness of this issue, and we urge them to make public the process they use to vet advertisements and what evidentiary standard they use for determining which treatments are appropriate to advertise."